Home page

Weike Biotechnology quality management department successfully passed the re-evaluation of CNAS expert group

Date：

2025-01-20 09:24

From January 11 to 12,2025, a team of three experts dispatched by the China National Accreditation Service for Conformity Assessment conducted a re-evaluation of our institution. The expert panel carried out a comprehensive review of the Quality Management Department over a period of two days. After a thorough evaluation, they announced that the Quality Management Department of Weike Biotechnology had successfully passed this re-evaluation.

During this re-evaluation, the expert panel conducted on-site inspections of the quality inspection laboratory and the animal experimental center, while also assessing the practical skills of the testing personnel. The panel reviewed the system operation, resource requirements, structural requirements, process requirements, and management requirements of the Quality Management Department according to standards/criteria. They carried out a comprehensive and detailed review of various aspects including document approval, supplier evaluation, customer service, corrective actions, internal audits and management reviews, personnel training, environmental facilities, instrument and equipment configuration, sample management, and result reporting.

Through on-site inspections and document reviews, the expert panel unanimously agreed that the personnel being evaluated were proficient in their operations and had complete records. The Quality Management Department basically met the requirements in terms of management systems, quality assurance, and technical capabilities, and could operate effectively and sustainably. During the technical exchange, the expert panel made constructive suggestions regarding enhancing laboratory standard material management and experimental animal management.

The quality management department passed the re-evaluation, which is the result of the continuous improvement of the quality management system by all the staff of the organization, and also fully reflects the companys constant emphasis on the professional level of testing.

"Sharpening the Sword to Move Forward, Wisely Painting the Future," Weike Biotechnology，as a technology transfer, product incubation, and industrialization base of the Harbin Veterinary Research Institute, continues to transform a series of scientific research achievements into productive forces. Using technology to lead the company forward and support industry development, Weike Biotechnology has always adhered to its original aspiration of "serving health with technology," driving innovation for development and winning the market through quality. Looking ahead, with the joint efforts of all Weike employees, Weike Biotechnology is sure to achieve its corporate vision of "creating industry leadership and reaching the pinnacle of technology"!